Initial AX-0810 data show no safety signals after 4 weeks of dosing and pharmacokinetics consistent with non-clinical data; ...

Bayer and Soufflé Therapeutics™, an innovative biotech company that discovers and develops cell-selective genetic therapies, ...

An announcement from PYC Therapeutics Limited ( ($AU:PYC) ) is now available. PYC Therapeutics has granted 2.5 million unlisted options to senior ...

SAN DIEGO, Nov. 10, 2025 /PRNewswire/ -- Primrose Bio, Inc. ("Primrose"), a company with proprietary therapeutic manufacturing technologies, today announced the launch of Prima RNApols™ ExTend Cap AU, ...

The ClearBridge Small Cap Strategy underperformed its Russell 2000 Index benchmark during the third quarter, despite registering gains in 10 of the 11 sectors in which it was invested during the ...

There is nobody at Euro 2025 like Sherida Spitse. At 35, the Netherlands and Ajax captain is the most-capped European player of all time (244 appearances) and she is set to extend that record this ...

ABSTRACT: Currently, no clinically approved therapeutic drugs specifically target dengue virus infections. This study aims to evaluate the potential of antiviral drugs originally developed for other ...

In the years after the 2020 COVID-19 pandemic, it is clear that mRNA as a modality for vaccines and therapeutics is here to stay based on the number of mRNA programs currently in clinical development.

Structure of the core of the Trypanosoma brucei nuclear cap-binding complex, bound to the capped RNA (in blacksticks). Credit: Harald Bernhard/EMBL, Daniela Velasco/EMBL The Kowalinski group at EMBL ...